amwell (previously known as american well) is a leading telehealth platform in the united states and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. amwell believes that digital care delivery will transform healthcare. the company offers a single, comprehensive platform to support all telehealth needs from urgent to acute and post-acute care, behavioral health, as well as chronic care management and healthy living. with over a decade of experience, amwell powers telehealth solutions for over 240 health systems comprised of 2,000 hospitals and 55 health plan partners with over 36,000 employers, reaching over 80 million lives.
Company profile
Ticker
AMWL
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Aligned Telehealth, LLC • American Well Israel Ltd • AMWELL Columbia SAS • Avizia LLC • National Telehealth Network, LLC • Conversa Health, LLC • SilverCloud Health Holdings, LLC • SilverCloud Health, Ltd. • SilverCloud Health UK Limited • SilverCloud Health Inc ...
AMWL stock data
Latest filings (excl ownership)
PRE 14A
Preliminary proxy
16 Apr 24
8-K
Amwell Receives Continued Listing Standard Notice From NYSE
4 Apr 24
S-8
Registration of securities for employees
16 Feb 24
10-K
2023 FY
Annual report
15 Feb 24
8-K
AMWELL ANNOUNCES RESULTS FOR Fourth QUARTER AND FULL YEAR 2023
14 Feb 24
8-K
Departure of Directors or Certain Officers
26 Dec 23
10-Q
2023 Q3
Quarterly report
1 Nov 23
8-K
AMWELL ANNOUNCES RESULTS FOR third QUARTER 2023
1 Nov 23
S-8
Registration of securities for employees
6 Oct 23
Transcripts
AMWL
Earnings call transcript
2023 Q4
14 Feb 24
AMWL
Earnings call transcript
2023 Q3
1 Nov 23
AMWL
Earnings call transcript
2023 Q2
2 Aug 23
AMWL
Earnings call transcript
2023 Q1
3 May 23
AMWL
Earnings call transcript
2022 Q4
22 Feb 23
AMWL
Earnings call transcript
2022 Q3
8 Nov 22
AMWL
Earnings call transcript
2022 Q2
5 Aug 22
AMWL
Earnings call transcript
2022 Q1
10 May 22
AMWL
Earnings call transcript
2021 Q4
25 Feb 22
AMWL
Earnings call transcript
2021 Q3
11 Nov 21
Latest ownership filings
4
Paul Francis McNeice
3 Apr 24
4
Phyllis Gotlib
3 Apr 24
4
Robert Shepardson
3 Apr 24
4
Kurt Knight
3 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
4
Paul Francis McNeice
12 Mar 24
4
Robert Shepardson
5 Mar 24
4
Phyllis Gotlib
5 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 320.17 mm | 320.17 mm | 320.17 mm | 320.17 mm | 320.17 mm | 320.17 mm |
Cash burn (monthly) | (no burn) | 1.10 mm | 47.79 mm | 58.34 mm | 12.66 mm | 11.89 mm |
Cash used (since last report) | n/a | 7.33 mm | 317.71 mm | 387.85 mm | 84.19 mm | 79.07 mm |
Cash remaining | n/a | 312.84 mm | 2.46 mm | -67.68 mm | 235.97 mm | 241.10 mm |
Runway (months of cash) | n/a | 283.8 | 0.1 | -1.2 | 18.6 | 20.3 |
Institutional ownership, Q3 2023
62.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 150 |
Opened positions | 25 |
Closed positions | 22 |
Increased positions | 47 |
Reduced positions | 44 |
13F shares | Current |
---|---|
Total value | 164.42 bn |
Total shares | 160.33 mm |
Total puts | 8.70 k |
Total calls | 1.06 mm |
Total put/call ratio | 0.0 |
Largest owners | Shares | Value |
---|---|---|
Senvest Management | 23.02 mm | $26.94 bn |
BLK Blackrock | 21.05 mm | $24.62 bn |
Vanguard | 17.41 mm | $20.37 bn |
Caledonia | 17.30 mm | $20.24 bn |
AZSEY Allianz Se | 11.34 mm | $68.51 mm |
TEVA Teva- Pharmaceutical Industries | 10.67 mm | $270.19 mm |
Satter Management | 10.48 mm | $12.26 bn |
STT State Street | 6.17 mm | $7.22 bn |
Geode Capital Management | 5.19 mm | $6.08 bn |
MS Morgan Stanley | 4.96 mm | $5.80 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | Paul Francis McNeice | Class A Common Stock | Sell | Dispose S | No | No | 0.7721 | 761 | 587.57 | 198,626 |
1 Apr 24 | Robert Shepardson | Class A Common Stock | Sell | Dispose S | No | No | 0.7721 | 7,569 | 5.84 k | 2,784,414 |
1 Apr 24 | Kurt Knight | Class A Common Stock | Sell | Dispose S | No | No | 0.7721 | 6,157 | 4.75 k | 3,081,414 |
1 Apr 24 | Phyllis Gotlib | Class A Common Stock | Sell | Dispose S | No | No | 0.7721 | 6,891 | 5.32 k | 2,459,579 |
8 Mar 24 | Paul Francis McNeice | Class A Common Stock | Sell | Dispose S | No | No | 1.0285 | 5,418 | 5.57 k | 197,865 |
News
Morgan Stanley Maintains Equal-Weight on American Well, Lowers Price Target to $1
15 Apr 24
Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
15 Feb 24
12 Health Care Stocks Moving In Thursday's Intraday Session
15 Feb 24
Reliance Steel & Aluminum Posts Upbeat Earnings, Joins JFrog, AppLovin, Shake Shack And Other Big Stocks Moving Higher On Thursday
15 Feb 24
American Well: Q4 Earnings Insights
14 Feb 24
Press releases
Amwell® to Report First Quarter 2024 Operating Results May 1
17 Apr 24
Amwell Receives Continued Listing Standard Notice From NYSE
4 Apr 24
Power of Amwell Hybrid Care Solutions to be Highlighted at HIMSS 2024
6 Mar 24
Amwell Names Cynthia Horner, M.D., Chief Medical Officer
22 Feb 24
Amwell to Participate in Upcoming Investor Conference
21 Feb 24